200 related articles for article (PubMed ID: 27014974)
1. Enhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis.
Li C; Jiang W; Hu Q; Li LC; Dong L; Chen R; Zhang Y; Tang Y; Thrasher JB; Liu CB; Li B
Oncotarget; 2016 Apr; 7(16):22893-910. PubMed ID: 27014974
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Prostate Cancer Metastasis by DPYSL3-Targeted saRNA.
Li B; Li C
Adv Exp Med Biol; 2017; 983():207-216. PubMed ID: 28639202
[TBL] [Abstract][Full Text] [Related]
3. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth.
Ren S; Kang MR; Wang J; Huang V; Place RF; Sun Y; Li LC
Prostate; 2013 Oct; 73(14):1591-601. PubMed ID: 23836514
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of PAWR by small activating RNAs induces cell apoptosis in human prostate cancer cells.
Yang K; Shen J; Chen SW; Qin J; Zheng XY; Xie LP
Oncol Rep; 2016 Apr; 35(4):2487-93. PubMed ID: 26797252
[TBL] [Abstract][Full Text] [Related]
5. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
[TBL] [Abstract][Full Text] [Related]
6. Suppression of migration and invasion of PC3 prostate cancer cell line via activating E-cadherin expression by small activating RNA.
Mao Q; Zheng X; Yang K; Qin J; Bai Y; Jia X; Li Y; Xie L
Cancer Invest; 2010 Dec; 28(10):1013-8. PubMed ID: 20690797
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of CRMP4, a new prostate cancer metastasis suppressor gene, inhibits tumor growth in a nude mouse intratibial injection model.
Zhou W; Xie P; Pang M; Yang B; Fang Y; Shu T; Liu C; Wang X; Zhang L; Li S; Rong L
Int J Oncol; 2015 Jan; 46(1):290-8. PubMed ID: 25338524
[TBL] [Abstract][Full Text] [Related]
8. Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis.
Wang C; Ge Q; Zhang Q; Chen Z; Hu J; Li F; Ye Z
J Exp Clin Cancer Res; 2016 Mar; 35():53. PubMed ID: 27012825
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
10. Promoter-targeted double-stranded small RNAs activate PAWR gene expression in human cancer cells.
Yang K; Shen J; Xie YQ; Lin YW; Qin J; Mao QQ; Zheng XY; Xie LP
Int J Biochem Cell Biol; 2013 Jul; 45(7):1338-46. PubMed ID: 23583662
[TBL] [Abstract][Full Text] [Related]
11. Calpain-2 triggers prostate cancer metastasis via enhancing CRMP4 promoter methylation through NF-κB/DNMT1 signaling pathway.
Gao X; Mao YH; Xiao C; Li K; Liu W; Li LY; Pang J
Prostate; 2018 Jun; 78(9):682-690. PubMed ID: 29601651
[TBL] [Abstract][Full Text] [Related]
12. Small activating RNA induced expression of VHL gene in renal cell carcinoma.
Kang MR; Park KH; Lee CW; Lee MY; Han SB; Li LC; Kang JS
Int J Biochem Cell Biol; 2018 Apr; 97():36-42. PubMed ID: 29425832
[TBL] [Abstract][Full Text] [Related]
13. Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy.
Wu X; Ding B; Gao J; Wang H; Fan W; Wang X; Zhang W; Wang X; Ye L; Zhang M; Ding X; Liu J; Zhu Q; Gao S
Int J Nanomedicine; 2011; 6():1747-56. PubMed ID: 21980237
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration.
Wang J; Place RF; Huang V; Wang X; Noonan EJ; Magyar CE; Huang J; Li LC
Cancer Res; 2010 Dec; 70(24):10182-91. PubMed ID: 21159640
[TBL] [Abstract][Full Text] [Related]
15. Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system.
Jing P; Cao S; Xiao S; Zhang X; Ke S; Ke F; Yu X; Wang L; Wang S; Luo Y; Zhong Z
Cancer Lett; 2016 Dec; 383(2):230-242. PubMed ID: 27721020
[TBL] [Abstract][Full Text] [Related]
16. Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells.
Guo Z; Huang H; Zeng L; Du T; Xu K; Lin T; Jiang C; Dong W; Cao Y; Chen J; Zhong W; Huang J
Med Oncol; 2011 Sep; 28(3):878-87. PubMed ID: 20390466
[TBL] [Abstract][Full Text] [Related]
17. DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer.
Matsunuma R; Chan DW; Kim BJ; Singh P; Han A; Saltzman AB; Cheng C; Lei JT; Wang J; Roberto da Silva L; Sahin E; Leng M; Fan C; Perou CM; Malovannaya A; Ellis MJ
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11978-E11987. PubMed ID: 30498031
[TBL] [Abstract][Full Text] [Related]
18. saKLK1-374 is more difficult to induce KLK1 expression in normal prostate cell lines than that in prostate cancer cell lines: Rethinking the universality of RNA activation.
Zhang M; Lin D; Luo C; Wei P; Cui K; Chen K; Chen Z
Biochem Biophys Res Commun; 2023 Feb; 643():157-168. PubMed ID: 36610381
[TBL] [Abstract][Full Text] [Related]
19. Antitumor Activity of Small Activating RNAs Induced PAWR Gene Activation in Human Bladder Cancer Cells.
Yang K; Shen J; Tan FQ; Zheng XY; Xie LP
Int J Med Sci; 2021; 18(13):3039-3049. PubMed ID: 34220332
[TBL] [Abstract][Full Text] [Related]
20. Promoter-associated small double-stranded RNA interacts with heterogeneous nuclear ribonucleoprotein A2/B1 to induce transcriptional activation.
Hu J; Chen Z; Xia D; Wu J; Xu H; Ye ZQ
Biochem J; 2012 Nov; 447(3):407-16. PubMed ID: 23035981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
